Developing a pathway to clinical trials for CACNA1A-related epilepsies: A patient organization perspective.
Saved in:
| Title: | Developing a pathway to clinical trials for CACNA1A-related epilepsies: A patient organization perspective. |
|---|---|
| Authors: | Fox PM; CACNA1A Foundation, Inc., 31 Pt Road, Norwalk, CT 06854, USA., Malepati S; CACNA1A Foundation, Inc., Norwalk, CT, USA., Manaster L; CACNA1A Foundation, Inc., Norwalk, CT, USA., Rossignol E; CACNA1A Foundation, Inc., Norwalk, CT, USA.; CHU Sainte-Justine Research Center, Departments of Neurosciences and Pediatrics, University of Montreal, Montreal, QC, Canada., Noebels JL; CACNA1A Foundation, Inc., Norwalk, CT, USA.; Blue Bird Circle Developmental Neurogenetics Laboratory, Department of Neurology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA. |
| Source: | Therapeutic advances in rare disease [Ther Adv Rare Dis] 2024 Apr 25; Vol. 5, pp. 26330040241245725. Date of Electronic Publication: 2024 Apr 25 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 9918557474706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2633-0040 (Electronic) Linking ISSN: 26330040 NLM ISO Abbreviation: Ther Adv Rare Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
